Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
Al-Samarai
A
A
Basrah Medical School, University of Basrah, Iraq.
Kinghorn
G
G
Potter
C
C
D000212:Acyclovir / Q000494:pharmacology / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D004347:Drug Interactions; D017245:Foscarnet; D006560:Herpes Labialis / Q000188:drug therapy*; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods; D009499:Neutral Red; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D018139:Simplexvirus / Q000187:drug effects* / Q000302:isolation & purification; D010948:Viral Plaque Assay
D000998:Antiviral Agents; D009943:Organophosphorus Compounds; D009499:Neutral Red; D017245:Foscarnet; D010746:Phosphonoacetic Acid; D000212:Acyclovir